Alternatives to Programmablebiology

Mapping cell-cell communication at scale in human tissue.

Biosynthesis of cannabinoids and psychedelics using advanced biotechnology.

Biotech company focused on designing and developing novel biological solutions.

AI-powered platform accelerating biological research and drug discovery.

Leveraging the adaptive immune system to diagnose and treat disease.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

Synthetic biology startup optimizing gene expression for food and biotech applications.

A global oncology company developing and commercializing innovative cancer treatments.

AI-powered platform for understanding disease biology and accelerating drug discovery.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

AI-guided drug discovery platform for tissue-targeted medicines.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Teknova provides critical reagents for biopharmaceutical product development and production.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

Vexxel is developing a novel platform for cell-free protein synthesis and engineering.

AI-powered platform for personalized cell therapy development and manufacturing.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Advance every cancer decision.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Seevix Material Sciences develops and produces SVX, a proprietary spider silk protein, for various industrial and medical applications.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

Gene therapy company developing transformative treatments for severe genetic diseases.

BioGene Therapeutics is a life sciences company developing novel gene therapy solutions for metabolic disorders like diabetes and obesity.

Gene therapy company developing treatments for rare inherited diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.

Personalized computational drug screening for rare diseases using patient genetics and automation.

Global marketplace connecting researchers with human biospecimens for life science research.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

AI-powered platform for designing novel molecular structures for new medicines.

AI-powered platform for antibody discovery and development to create new medicines.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Biotechnology company

A vertically-integrated procurement platform for the life sciences industry.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Biostax provides a cloud-based platform for life sciences research, enabling data integration and analysis.